SCHEMBL7690997

SCHEMBL7690997

Cc1cccc(C)c1CC(=O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 3/20 0.48
FEN1 P39748 3/20 0.48
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CTBP2 P56545 1/20 0.42
SLC22A12 Q96S37 2/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGS2 P35354 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
PTPN1 P18031 1/20 0.38
AKR1B1 P15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877955 0.82 TDP1 (0.57) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL1004574 0.82 KDM4E (0.58) KDM4EMEN1GAAMAPTKMT2A
SCHEMBL12214127 0.79 KDM4E (0.42) KDM4EMEN1GAAMAPTKMT2A
SCHEMBL9283073 0.79 KDM4E (0.40) ERCC5FEN1KDM4EMEN1GAA
SCHEMBL19465023 0.78 NPC1 (0.42) ERCC5FEN1MEN1MAPTKMT2A
SCHEMBL1258876 0.77 KDM4E (0.41) KDM4EMEN1GAAMAPTKMT2A
SCHEMBL15304521 0.77 KDM4E (0.41) KDM4EMEN1GAAMAPTKMT2A
SCHEMBL2935163 0.77 CTBP2 (0.62) ERCC5FEN1KDM4EMEN1GAA
SCHEMBL9267218 0.76 KDM4E (0.40) KDM4EMEN1GAAMAPTKMT2A
SCHEMBL436968 0.76 PLA2G2A (0.41) KDM4EMEN1GAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002090360-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-11-14 WO disclosed